Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
Details for Australian Patent Application No. 2002340372 (hide)
International Classifications
Event Publications
27 February 2003 Complete Application Filed
Priority application(s): 60/337,762 08.11.01 US
24 July 2003 Application Open to Public Inspection
Published as AU-B-2002340372
3 June 2004 Amendment Made
The nature of the amendment is: Amend the name of the applicant/patentee from OrthoMcNeil Pharmaceutical Corporation to Ortho-McNeil Pharmaceutical, Inc.
11 December 2008 Application Accepted
Published as AU-B-2002340372
9 April 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002340373-METHODS, SYSTEMS, AND KITS FOR ANALYSIS OF POLYNUCLEOTIDES
2002340371-MULTIPLE-ACCESS MULTIPLE-INPUT MULTIPLE-OUTPUT (MIMO) COMMUNICATION SYSTEM
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser